Table 2.
Pros | Cons |
---|---|
Economically reasonable and well-tolerated | Off-label use |
Except for hypocholesterolemia | Hypercholesterolemia |
Favorable for malignancies? | Carcinogenic? |
Many observational studies | Biases |
Statins improve cardiovascular outcomes | Lipid-lowering drugs may not necessarily improve all causes of death |